ID29576A - Komposisi-komposisi mukoadesif cair oral - Google Patents
Komposisi-komposisi mukoadesif cair oralInfo
- Publication number
- ID29576A ID29576A IDW20010449A ID20010449A ID29576A ID 29576 A ID29576 A ID 29576A ID W20010449 A IDW20010449 A ID W20010449A ID 20010449 A ID20010449 A ID 20010449A ID 29576 A ID29576 A ID 29576A
- Authority
- ID
- Indonesia
- Prior art keywords
- composition
- safe
- mixtures
- effective amount
- respiratory tract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9757898P | 1998-08-24 | 1998-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29576A true ID29576A (id) | 2001-09-06 |
Family
ID=22264129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20010449A ID29576A (id) | 1998-08-24 | 1999-08-24 | Komposisi-komposisi mukoadesif cair oral |
Country Status (17)
Country | Link |
---|---|
US (1) | US6319513B1 (fr) |
EP (1) | EP1107733B1 (fr) |
JP (1) | JP2002523354A (fr) |
KR (1) | KR100413877B1 (fr) |
CN (1) | CN1195494C (fr) |
AT (1) | ATE300282T1 (fr) |
AU (1) | AU761968B2 (fr) |
BR (1) | BR9913178B1 (fr) |
CA (1) | CA2338704C (fr) |
CO (1) | CO5140082A1 (fr) |
DE (1) | DE69926377T2 (fr) |
HU (1) | HUP0103388A3 (fr) |
ID (1) | ID29576A (fr) |
NO (1) | NO20010832L (fr) |
PE (1) | PE20000862A1 (fr) |
TR (1) | TR200100628T2 (fr) |
WO (1) | WO2000010529A1 (fr) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223416B2 (en) * | 1999-06-28 | 2007-05-29 | Minu, L.L.C. | Topical composition |
DE60044251D1 (de) * | 1999-07-02 | 2010-06-02 | Mitsubishi Gas Chemical Co | Zusammensetzungen für die zahnbleiche und verfahren zur bleiche von verfärbten zähnen |
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US20060083691A1 (en) * | 2000-05-10 | 2006-04-20 | Wermeling Daniel P | Intranasal opioid compositions, delivery devices and methods of using same |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
JP4822652B2 (ja) * | 2000-11-22 | 2011-11-24 | エンド ファーマシューティカルズ インコーポレイテッド | 粘膜炎の治療 |
FR2822709B1 (fr) * | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
US7927600B2 (en) * | 2001-03-30 | 2011-04-19 | Emile Loria | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
WO2003013548A1 (fr) * | 2001-08-09 | 2003-02-20 | Sekisui Chemical Co., Ltd. | Composition medicale a usage externe destinee au traitement des dermatoses |
WO2003017960A1 (fr) * | 2001-08-24 | 2003-03-06 | Mintaco Inc. | Bain de bouche pour le traitement et la prevention d'infections bacteriennes et fongiques |
US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US8425892B2 (en) * | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
PL211494B1 (pl) * | 2001-12-21 | 2012-05-31 | Alcon | Zastosowanie syntetycznych, nieorganicznych nanocząstek jako nośników dla leków i kompozycja farmaceutyczna do oczu lub uszu |
EP1467715B1 (fr) * | 2002-01-15 | 2010-11-03 | Ucb Farchim S.A. | Formulations pour l'adminstration orale de composes actifs |
BG65734B1 (bg) * | 2002-02-22 | 2009-09-30 | Био Терапютикс - Еоод | Течен мукоадхезивен фармацевтичен състав |
US20030166732A1 (en) * | 2002-02-27 | 2003-09-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
WO2003086363A1 (fr) * | 2002-04-08 | 2003-10-23 | Lavipharm Laboratories Inc. | Microparticules complexe-medicament et procedes et utilisations correspondants |
AU2003246791A1 (en) * | 2002-04-09 | 2003-10-20 | Flamel Technologies | Oral suspension of amoxicillin capsules |
US6919348B2 (en) * | 2002-05-02 | 2005-07-19 | Edward T. Wei | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
MXPA04011019A (es) * | 2002-05-07 | 2005-01-25 | Altana Pharma Ag | Combinacion de un inhibidor de la bomba de protones y un agente respiratorio, para el tratamiento de trastornos de las vias respiratorias. |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
DE122011100019I1 (de) | 2003-01-21 | 2011-11-03 | Senju Pharma Co | Wassrige flussige zubereitung mit 2-amino-3-(4-bromobenzoyl) phenylessigsaure. |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US7459146B2 (en) * | 2003-05-30 | 2008-12-02 | 3M Innovative Properties Company | Stabilized aerosol dispersions |
US20040242729A1 (en) * | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
US7109247B2 (en) * | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
US20050154343A1 (en) * | 2004-01-14 | 2005-07-14 | Mohinder Singh | Soft tip applicator for relieving mouth pain |
US20050266031A1 (en) * | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US7482378B2 (en) * | 2004-05-28 | 2009-01-27 | Millenium Specialty Chemicals, Inc. | Physiological cooling compositions |
WO2006020190A1 (fr) * | 2004-07-16 | 2006-02-23 | Richard Plymale | Composition dentifrice |
WO2006026337A1 (fr) * | 2004-08-25 | 2006-03-09 | Fairfield Clinical Trials, Llc | Association d’un inhibiteur de la pompe à proton et d’un antagoniste du récepteur h2 pour le traitement du reflux gastro-œsophagien |
DK2377557T3 (en) | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US20060210482A1 (en) * | 2005-03-18 | 2006-09-21 | John Cassara | Chemical composition and method for cold and sinus relief |
US7985743B1 (en) * | 2005-07-22 | 2011-07-26 | Gene A. Tabish | Topical pain reliever and method of making the same |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
AU2006320538B2 (en) * | 2005-11-30 | 2013-07-04 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
DOP2006000274A (es) * | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
WO2007117704A2 (fr) * | 2006-04-07 | 2007-10-18 | Michalis Nicolaou | Isomeres de tritoqualine purs |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
WO2008100539A1 (fr) * | 2007-02-12 | 2008-08-21 | Michalis Nicolaou | Traitement de la maladie pulmonaire obstructive chonique (mpoc), du reflux gastro-oesophagien pathologique (gerd), des allergies alimentaires et autres affections et troubles gastro-intestinaux attenues par une gestion appropriee de l'histamine au moyen d'une combinaison d'inhibiteurs d'histidine decarboxylase, de medicamen |
US8895061B2 (en) * | 2007-03-02 | 2014-11-25 | Meda Pharmaceuticals Inc. | Compositions comprising carisoprodol and methods of use thereof |
AU2014201068B2 (en) * | 2007-06-08 | 2016-07-07 | The Procter & Gamble Company | Natural honey-containing compositions and method of preparation |
PL2002733T3 (pl) * | 2007-06-08 | 2017-06-30 | The Procter And Gamble Company | Kompozycja zawierająca miód naturalny i sposoby jej sporządzania |
ITMI20071623A1 (it) * | 2007-08-03 | 2009-02-04 | Vetagro S R L | Composizione sinergica comprendente sostanze aromatizzanti ed acidi organici, e relativo uso |
CA2704946C (fr) | 2007-11-13 | 2013-09-24 | Meritage Pharma, Inc. | Compositions pour le traitement de l'inflammation des voies gastro-intestinales |
KR20190026056A (ko) | 2008-04-21 | 2019-03-12 | 오토노미, 인코포레이티드 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
GB0807621D0 (en) * | 2008-04-25 | 2008-06-04 | Ineos Healthcare Ltd | Use |
US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
CN102105133B (zh) | 2008-07-21 | 2015-06-17 | 奥德纳米有限公司 | 控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法 |
US7914828B2 (en) * | 2008-10-17 | 2011-03-29 | Levine Brian M | Combination herbal product to benefit respiratory tract |
GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US8361519B2 (en) | 2010-11-18 | 2013-01-29 | Aadvantics Pharmaceuticals, Inc. | Combination herbal product to benefit respiratory tract in people exposed to smoke |
US20140213644A1 (en) * | 2010-12-30 | 2014-07-31 | Ziv Harish | Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome |
MX366533B (es) * | 2012-12-06 | 2019-07-12 | Colgate Palmolive Co | Gel oral para sensibilidad y dolor dental. |
EP3061501A1 (fr) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition pour le traitement de l'acné |
EP3117825A1 (fr) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Formulation orale comprenant de la berbérine et un extrait de morus alba |
US20170029511A1 (en) | 2015-07-28 | 2017-02-02 | Otonomy, Inc. | Trkb or trkc agonist compositions and methods for the treatment of otic conditions |
US10959932B2 (en) | 2015-12-30 | 2021-03-30 | Colgate-Palmolive Company | Mucin coated silica for bacterial aggregation |
CN109689027A (zh) | 2016-06-29 | 2019-04-26 | 奥德纳米有限公司 | 甘油三酯耳用制剂及其用途 |
US10583081B1 (en) * | 2017-11-27 | 2020-03-10 | Richard A. Myers | Apparatus and formulation for treating mouth ulcers |
WO2019154895A1 (fr) | 2018-02-08 | 2019-08-15 | Strekin Ag | Formulation en gel pour la prévention ou le traitement de la perte auditive |
US20210244710A1 (en) * | 2018-07-02 | 2021-08-12 | Kangping Xiao | Stable pharmaceutical formulations of oxymetazoline |
HRP20211996T1 (hr) | 2018-09-11 | 2022-04-01 | Lead Biotherapeutics Ltd. | Sustav mukoadhezivne disperzijske nanočestice i metoda proizvodnje istog |
WO2020168289A1 (fr) * | 2019-02-15 | 2020-08-20 | Ferrer Medical Innovations, LLC | Compositions de pulvérisation nasale et procédés de traitement associés |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3352752A (en) | 1963-07-25 | 1967-11-14 | Tintex Corp | Intestinal adsorbent compositions |
JPS589083B2 (ja) | 1975-05-30 | 1983-02-18 | 武田薬品工業株式会社 | シヨウリユウザイノセイゾウホウ |
FR2346017A1 (fr) | 1975-10-23 | 1977-10-28 | Rech Applic Scient | Composition therapeutique pour le traitement des affections du tractus gastro-intestinal |
FR2502956A1 (fr) * | 1981-04-01 | 1982-10-08 | Human Pharm Sa Laboratoires | Composition therapeutique utile comme topique digestif |
US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
JPS61106509A (ja) * | 1984-10-29 | 1986-05-24 | Fujisawa Pharmaceut Co Ltd | 鼻腔用医薬組成物 |
AU594765B2 (en) | 1986-05-16 | 1990-03-15 | Chugai Seiyaku Kabushiki Kaisha | Sucralfate preparations for applications on esophagus mucosa |
US5464828A (en) | 1988-03-02 | 1995-11-07 | Chugai Pharmaceutical Co., Ltd. | Aqueous suspension of sucralfate |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5047244A (en) | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
WO1991006289A1 (fr) | 1989-10-31 | 1991-05-16 | Watson Laboratories, Inc. | Support muco-adhesif servant a liberer un agent therapeutique |
JPH0639368B2 (ja) | 1990-02-28 | 1994-05-25 | 株式会社萩原技研 | シリカゲルを母体とした抗菌性組生物 |
GB9025710D0 (en) | 1990-11-27 | 1991-01-09 | Beecham Group Plc | Novel treatment |
DE59202096D1 (de) | 1991-06-07 | 1995-06-08 | Byk Gulden Lomberg Chem Fab | Pharmazeutische klistierzubereitung. |
IT1251153B (it) | 1991-08-06 | 1995-05-04 | Vectorpharma Int | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
JPH0725769A (ja) * | 1992-10-20 | 1995-01-27 | Fuji Chem Ind Co Ltd | アロプリノール医薬用液剤ならびにその製造法 |
FR2710265B1 (fr) | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US5670163A (en) | 1994-06-20 | 1997-09-23 | Kv Pharmaceuticals Company | Long acting GI and esophageal protectant |
US5554379A (en) | 1994-06-20 | 1996-09-10 | Kv Pharmaceutical Company | Long acting GI and esophageal protectant |
US5554380A (en) | 1994-08-04 | 1996-09-10 | Kv Pharmaceutical Company | Bioadhesive pharmaceutical delivery system |
US5585108A (en) | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
US5466440A (en) | 1994-12-30 | 1995-11-14 | Eastman Kodak Company | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays |
JP3927253B2 (ja) * | 1995-02-02 | 2007-06-06 | 中外製薬株式会社 | スクラルファート製剤 |
US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
FR2739558B1 (fr) | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
-
1999
- 1999-07-27 US US09/361,533 patent/US6319513B1/en not_active Expired - Lifetime
- 1999-08-24 AU AU55809/99A patent/AU761968B2/en not_active Ceased
- 1999-08-24 TR TR2001/00628T patent/TR200100628T2/xx unknown
- 1999-08-24 CA CA002338704A patent/CA2338704C/fr not_active Expired - Fee Related
- 1999-08-24 DE DE69926377T patent/DE69926377T2/de not_active Expired - Lifetime
- 1999-08-24 AT AT99942429T patent/ATE300282T1/de not_active IP Right Cessation
- 1999-08-24 JP JP2000565851A patent/JP2002523354A/ja active Pending
- 1999-08-24 WO PCT/US1999/019202 patent/WO2000010529A1/fr not_active Application Discontinuation
- 1999-08-24 BR BRPI9913178-1A patent/BR9913178B1/pt not_active IP Right Cessation
- 1999-08-24 CN CNB998098604A patent/CN1195494C/zh not_active Expired - Fee Related
- 1999-08-24 ID IDW20010449A patent/ID29576A/id unknown
- 1999-08-24 CO CO99053437A patent/CO5140082A1/es unknown
- 1999-08-24 EP EP99942429A patent/EP1107733B1/fr not_active Expired - Lifetime
- 1999-08-24 PE PE1999000848A patent/PE20000862A1/es not_active Application Discontinuation
- 1999-08-24 HU HU0103388A patent/HUP0103388A3/hu unknown
- 1999-08-24 KR KR10-2001-7001965A patent/KR100413877B1/ko not_active IP Right Cessation
-
2001
- 2001-02-19 NO NO20010832A patent/NO20010832L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9913178A (pt) | 2001-05-15 |
ATE300282T1 (de) | 2005-08-15 |
DE69926377T2 (de) | 2006-06-01 |
PE20000862A1 (es) | 2000-09-13 |
NO20010832D0 (no) | 2001-02-19 |
HUP0103388A2 (hu) | 2002-01-28 |
AU5580999A (en) | 2000-03-14 |
EP1107733A1 (fr) | 2001-06-20 |
DE69926377D1 (de) | 2005-09-01 |
KR100413877B1 (ko) | 2004-01-07 |
NO20010832L (no) | 2001-02-19 |
CA2338704C (fr) | 2004-11-02 |
WO2000010529A1 (fr) | 2000-03-02 |
TR200100628T2 (tr) | 2001-10-22 |
US6319513B1 (en) | 2001-11-20 |
JP2002523354A (ja) | 2002-07-30 |
CA2338704A1 (fr) | 2000-03-02 |
KR20010072678A (ko) | 2001-07-31 |
HUP0103388A3 (en) | 2006-02-28 |
EP1107733B1 (fr) | 2005-07-27 |
CO5140082A1 (es) | 2002-03-22 |
BR9913178B1 (pt) | 2014-11-25 |
CN1195494C (zh) | 2005-04-06 |
AU761968B2 (en) | 2003-06-12 |
CN1313756A (zh) | 2001-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID29576A (id) | Komposisi-komposisi mukoadesif cair oral | |
DE69904057D1 (de) | Orale flüssige mucoadhäsive zusammensetzungen | |
JPH0161086B2 (fr) | ||
JPH03197430A (ja) | 呼吸器管感染症用スプレー剤 | |
WO1999059544A3 (fr) | Comprimes se desintegrant dans la bouche | |
CA2321819A1 (fr) | Compositions de xylitol destinees au traitement des pathologies des voies respiratoires superieures | |
WO1994008551A3 (fr) | Procedes et compositions pharmaceutiques destines au traitement des symptomes du rhume | |
JP2004525903A5 (fr) | ||
CA2277365A1 (fr) | Traitement de la sclerose en plaques par l'ingestion ou l'inhalation de copolymere-1 | |
FR2712807B1 (fr) | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . | |
WO2003015746A1 (fr) | Composition de nettoyage des voies nasales | |
DE69903651D1 (de) | Orale flüssige mucoadhäsive zusammensetzungen | |
WO2001012128A3 (fr) | Formes posologiques seches d'agents antibacteriens a usage topique pour traiter des infections aigues des muqueuses de la cavite buccale | |
JP2001139465A (ja) | 咽頭粘膜用組成物 | |
JP2007022971A (ja) | 経鼻投与のための組成物 | |
JP2002145764A (ja) | 咽頭粘膜用組成物 | |
RU2001126302A (ru) | Способ терапевтического или профилактического лечения стрептококковых инфекций (варианты) и композиция, предназначенная для использования в нем (варианты), лизин, ассоциированный с фагом стрептококков группы C, - активный агент фармацевтической композиции | |
BR0205625C1 (pt) | Formulações nasais em gel |